Abstract:Endothelial PDGFR‐β plays a pivotal role in osteoporosis by modulating angiogenesis‐associated osteogenesis. Endothelial PDGFR‐β exerts regulatory control over H‐type vessel formation through the PDGFRβ‐PAK1‐NICD signaling cascade. Depletion of PDGFR‐β or interruption of PAK1/NICD axis in endothelial cells (ECs) ameliorates vessel formation and its mediated bone formation, while overexpression of PDGFR‐β reverses this phenomenon. The intricate orchestration of osteoporosis (OP) pathogenesis remains elusive. Mounting evidence suggests that angiogenesis‐driven osteogenesis serves as a crucial foundation for maintaining bone homeostasis. This study aimed to explore the potential of the endothelial platelet‐derived growth factor receptor‐β (PDGFR‐β) in mitigating bone loss through its facilitation of H‐type vessel formation. Our findings demonstrate that the expression level of endothelial PDGFR‐β is reduced in samples obtained from individuals suffering from OP, as well as in ovariectomy mice. Depletion of PDGFR‐β in endothelial cells ameliorates angiogenesis‐mediated bone formation in mice. The regulatory influence of endothelial PDGFR‐β on H‐type vessels is mediated through the PDGFRβ‐P21‐activated kinase 1‐Notch1 intracellular domain signaling cascade. In particular, the endothelium‐specific enhancement of PDGFR‐β facilitates H‐type vessels and their associated bone formation in OP. Hence, the strategic targeting of endothelial PDGFR‐β emerges as a promising therapeutic approach for the management of OP in the near future.

Research progress on the role of angiogenesis in bone metabolism and osteoporosis

Research and Application of Target Therapy for Osteoporosis

Advances in nutritional intervention of osteoporosis

Osteopontin in Bone Metabolism and Bone Diseases

Research progress and application of OPG/RANK/RANKL signaling pathway in osteoporosis

Role of miRNA-regulated type H vessel formation in osteoporosis

Research progress on the angiogenic-osteogenic coupling signaling molecules of bone tissue engineering

Recent Progresses in the Treatment of Osteoporosis

Research Progress of the Molecular Signal Pathway in the Prevention and Treatment of Osteoporosis

Advances in the understanding of the role of type-H vessels in the pathogenesis of osteoporosis

The research progress in the role of microRNAs in the pathogenesis of osteoporosis

Research Progress of RANK/RANKL/OPG Signaling Pathway

Advances in the occurrence and biotherapy of osteoporosis.

Research progress on drugs in osteoporosis therapy

Exploring the effect of the "quaternary regulation" theory of "peripheral nerve-angiogenesis-osteoclast-osteogenesis" on osteoporosis based on neuropeptides

Research Progress on the Involvement of PI3K-AKT Signaling Pathway in the Pathogenesis of Osteoporosis

Targeting endothelial PDGFR‐β facilitates angiogenesis‐associated bone formation through the PAK1/NICD axis

Research Progress on Pathogenesis of Osteoporosis

The Roles of Epigenetics Regulation in Bone Metabolism and Osteoporosis

Advances in imaging research of bone marrow microenvironment in osteoporosis

The Effect of Exercise on the Prevention of Osteoporosis and Bone Angiogenesis